To evaluate the capacity of TZ‐dSA3‐12 to activate STING signaling in cancer cells, we treated these cells with vehicle (PBS), dSA3, TZ, or TZ‐dSA3‐12 for either 6 or 24 h. The gene discussed is STING1; the disease is cancer.